APA (7th ed.) Citation

Nasser, A., Liranso, T., Adewole, T., Fry, N., Hull, J. T., Busse, G. D., . . . Schwabe, S. (2021). A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder. Journal of clinical psychopharmacology, 41(4), 370. https://doi.org/10.1097/JCP.0000000000001404

Chicago Style (17th ed.) Citation

Nasser, Azmi, et al. "A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder." Journal of Clinical Psychopharmacology 41, no. 4 (2021): 370. https://doi.org/10.1097/JCP.0000000000001404.

MLA (9th ed.) Citation

Nasser, Azmi, et al. "A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder." Journal of Clinical Psychopharmacology, vol. 41, no. 4, 2021, p. 370, https://doi.org/10.1097/JCP.0000000000001404.